2024-519381-53-00CompletedPhase 1
A study to find out how healthy people tolerate a new drug called S221237.
Source: EU CTIS (euclinicaltrials.eu) · Last updated 13 Nov 2024
- Status (registry)
- Completed
- Phase (registry)
- Phase 1
- Study type
- Interventional
- Enrollment
- 103 (actual)
- First submitted
- 7 Nov 2024
- Start date
- 4 Oct 2022
- Lead sponsor
- Institut De Recherches Internationales Servier IRIS
- EU CT number
- 2024-519381-53-00
- EudraCT number
- 2022-001526-30
What you commit to
- Study type: Interventional · Phase 1
- Participants enrolled: 103
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of EU CTIS (euclinicaltrials.eu). It describes the study design.
Sites (1)
Sites in registry order. Save your city in your profile to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Eurofins Optimed | Gières | France | Completed |
This page is information, not medical advice. Discuss any trial with your doctor.